Aslan Pharmaceuticals plan private placement of up to 45 mln shares
Oct 23 (Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO> ::Says it plans to issue up to 45 million new shares via private placement, with details remaining to be determined .
Latest Developments forAslan Pharmaceuticals Ltd
- Aslan Pharmaceuticals Files For Offering Of 4.6 Mln American Depositary Shares Representing 23.1 Mln Ordinary Shares
- Aslan Pharmaceuticals Acquires Full Global Commercial Rights For ASLAN004 From CSL
- Aslan Pharmaceuticals Qtrly Basic Loss Per Share $0.07
- Aslan Pharmaceuticals Files For Proposed IPO In U.S.
Latest Key Developments inPharmaceuticals
- Celgene Says FDA Approves Otezla (Apremilast) For Treatment Of Oral Ulcers Associated With Behçet’s Disease
- Bayer Statement On Voluntary Recall Of Two Lots Of Kogenate FS Antihemophilic Factor In U.S.
- Health Canada Says Pfizer Confirms EpiPen 0.3 Mg Supply Is Currently Available And Continues To Be Shipped
- Statement From Health Canada On The Supply Of EpiPen 0.3 Mg Auto-Injectors